Drug Screening
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
14
NCT05263583
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 9, 2022
Completion: Jun 30, 2025
Loading map...